Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Miyuki Matsukawa
ResearcherPublications, citations & collaboration network
Miyuki Matsukawa is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 18 works, 259 citations, an h-index of 8 and an i10-index of 7.
18
Works
259
Citations
8
h-index
7
i10-index
IDs:OpenAlex
How has Miyuki Matsukawa's publication output changed over time?
ScholarIQpublication output · 2006–2025
Output grew0% over the shown period — from 1 works in 2006 to 1 in 2025.
1
1
1
4
3
1
200620152017201820192025
What are the most-cited papers on Miyuki Matsukawa?
ScholarIQmost cited works
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
M. Wafik Gouda, Miyuki Matsukawa, Hiroaki Iijima
Diabetes Metabolic Syndrome and Obesity. 201851 CitationsOPEN ACCESS
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan
Shigeaki Ohno, Itsuro Umebayashi, Miyuki Matsukawa, Takashi Goto, Toshiro Yano
Arthritis Research & Therapy. 201951 CitationsOPEN ACCESS
Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post‐marketing surveillance
Hideshi Torii, Tadashi Terui, Miyuki Matsukawa, Kazumi Takesaki, Mamitaro Ohtsuki, Hidemi Nakagawa
The Journal of Dermatology. 201544 Citations
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease
Masaru Miura, Tohru Kobayashi, Toru Igarashi, Hiromichi Hamada, Naomi Iwata, Yoshifumi Sasaki, Miyuki Matsukawa, Noriko Sato, Hajime Kubo, Syuji Takei
S109369870. 201930 CitationsOPEN ACCESS
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki, Miyuki Matsukawa, Yuka Yamada
Advances in Therapy. 201925 CitationsOPEN ACCESS
Related on ScholarIQ
Otsuka (Japan)
Institution
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
Paper
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet’s disease: a large-scale, long-term postmarketing surveillance in Japan
Paper
Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post‐marketing surveillance
Paper
Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease
Paper
Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
Paper